Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy
Cancer Medicine · 2024
DOI: 10.1002/cam4.7453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Yanan Sun und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nomograms, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Haiyan Foundation of the Harbin Medical University Cancer Hospital.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
The purpose of the study is to construct meaningful nomogram models according to the independent prognostic factor for metastatic pancreatic cancer receiving chemotherapy.
Methods
This study is retrospective and consecutively included 143 patients from January 2013 to June 2021. The receiver operating characteristic (ROC) curve with the area under the curve (AUC) is utilized to determine the optimal cut‐off value. The Kaplan–Meier survival analysis, univariate and multivariable Cox regression analysis are exploited to identify the correlation of inflammatory biomarkers and clinicopathological features with survival. R software are run to construct nomograms based on independent risk factors to visualize survival. Nomogram model is examined using calibration curve and decision curve analysis (DCA).
Results
The best cut‐off values of 966.71, 0.257, and 2.54 for the systemic immunological inflammation index (SII), monocyte‐to‐lymphocyte ratio (MLR), and neutrophil‐to‐lymphocyte ratio (NLR) were obtained by ROC analysis. Cox proportional‐hazards model revealed that baseline SII, history of drinking and metastasis sites were independent prognostic indices for survival. We established prognostic nomograms for primary endpoints of this study. The nomograms' predictive potential and clinical efficacy have been evaluated by calibration curves and DCA.
Conclusion
We constructed nomograms based on independent prognostic factors, these models have promising applications in clinical practice to assist clinicians in personalizing the management of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
- Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
- Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, China.
ORCID-Profile: Yanan Sun, Jiahe Hu, Xiaoling Zhang, Rui Xie
Förderung
- The Haiyan Foundation of the Harbin Medical University Cancer Hospital
Zitieren
APA
Sun, Y., Hu, J., Wang, R., Du, X., Zhang, X., E, J., Zheng, S., Zhou, Y., Mou, R., Li, X., Zhang, H., Xu, Y., Liao, Y., Jiang, W., Liu, L., Wang, R., Zhu, J., & Xie, R. (2024). Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.7453
Vancouver
Sun Y, Hu J, Wang R, Du X, Zhang X, E J, et al. Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy. Cancer Medicine. 2024. doi:10.1002/cam4.7453
BibTeX
@article{Sun2024,
author = {Sun, Yanan and Hu, Jiahe and Wang, Rongfang and Du, Xinlian and Zhang, Xiaoling and E, Jiaoting and Zheng, Shaoyue and Zhou, Yuxin and Mou, Ruishu and Li, Xuedong and Zhang, Hanbo and Xu, Ying and Liao, Yuan and Jiang, Wenjie and Liu, Lijia and Wang, Ruitao and Zhu, Jiuxin and Xie, Rui},
title = {Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7453}
}
EUVIMED